Data / Form D filings / Biowise Capital II, LLC
Biowise Capital II, LLC: Form D filings
Biowise Capital II, LLC, a biotechnology company in Dallas, TX, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on November 15, 2023, reports $1.1 million sold of a $10 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 CRESCENT COURT,, #700, Dallas, TX, 75201
- Phone
- (214) 810-4339
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Texas
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c), Investment Company Act section 3(c), section 3(c)(1)
- SEC identifier (CIK)
- 1844785
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 15, 2023 | Amendment | $10,000,000 | $1,100,000 | $8,900,000 | 14 | Mar 1, 2021 | sec.gov |
| Feb 8, 2021 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Amir Baluch | Executive Officer |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Nov 13, 2023 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Biowise Capital II, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.